LPL Financial LLC purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 57,487 shares of the medical instruments supplier’s stock, valued at approximately $1,830,000.
Other large investors also recently modified their holdings of the company. Ellevest Inc. raised its position in DENTSPLY SIRONA by 281.2% during the 3rd quarter. Ellevest Inc. now owns 1,216 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 897 shares during the last quarter. Eisler Capital UK Ltd. bought a new position in DENTSPLY SIRONA during the 3rd quarter worth $45,000. Parkside Financial Bank & Trust raised its position in DENTSPLY SIRONA by 163.7% during the 1st quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock worth $46,000 after purchasing an additional 568 shares during the last quarter. Signaturefd LLC raised its position in DENTSPLY SIRONA by 20.8% during the 4th quarter. Signaturefd LLC now owns 1,973 shares of the medical instruments supplier’s stock worth $63,000 after purchasing an additional 340 shares during the last quarter. Finally, Neo Ivy Capital Management raised its position in DENTSPLY SIRONA by 117.4% during the 3rd quarter. Neo Ivy Capital Management now owns 4,196 shares of the medical instruments supplier’s stock worth $119,000 after purchasing an additional 2,266 shares during the last quarter. 98.52% of the stock is currently owned by institutional investors.
DENTSPLY SIRONA Trading Down 3.5 %
Shares of NASDAQ XRAY opened at $38.05 on Wednesday. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.48 and a fifty-two week high of $43.24. The company has a quick ratio of 0.93, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The firm’s 50-day simple moving average is $39.80 and its 200 day simple moving average is $36.02.
DENTSPLY SIRONA Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, April 14th. Shareholders of record on Friday, March 31st were given a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, March 30th. This represents a $0.50 annualized dividend and a dividend yield of 1.31%.
Wall Street Analysts Forecast Growth
XRAY has been the subject of several analyst reports. The Goldman Sachs Group raised their target price on DENTSPLY SIRONA from $34.00 to $39.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 1st. Morgan Stanley increased their price target on DENTSPLY SIRONA from $39.00 to $45.00 and gave the stock an “overweight” rating in a report on Wednesday, April 19th. Barrington Research raised their target price on DENTSPLY SIRONA from $43.00 to $51.00 in a research note on Thursday, May 4th. Piper Sandler raised their target price on DENTSPLY SIRONA from $29.00 to $35.00 and gave the company a “neutral” rating in a research note on Monday, February 6th. Finally, StockNews.com began coverage on DENTSPLY SIRONA in a research note on Thursday, May 18th. They issued a “buy” rating for the company. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $42.13.
Insiders Place Their Bets
In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,200 shares of DENTSPLY SIRONA stock in a transaction that occurred on Tuesday, May 2nd. The shares were sold at an average price of $42.17, for a total transaction of $261,454.00. Following the transaction, the director now owns 44,902 shares of the company’s stock, valued at approximately $1,893,517.34. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, Director Eric Brandt sold 6,200 shares of DENTSPLY SIRONA stock in a transaction that occurred on Tuesday, May 2nd. The shares were sold at an average price of $42.17, for a total value of $261,454.00. Following the sale, the director now owns 44,902 shares of the company’s stock, valued at approximately $1,893,517.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Cord Friedrich Staehler sold 4,000 shares of DENTSPLY SIRONA stock in a transaction that occurred on Tuesday, March 7th. The stock was sold at an average price of $39.33, for a total transaction of $157,320.00. Following the completion of the sale, the senior vice president now directly owns 97,693 shares in the company, valued at approximately $3,842,265.69. The disclosure for this sale can be found here. Insiders own 0.76% of the company’s stock.
About DENTSPLY SIRONA
Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.
Recommended Stories
- Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
